Skip to main content
NCBI home page
Gut logoLink to Gut
. 2002 May;50(Suppl 3):iii37–iii42. doi: 10.1136/gut.50.suppl_3.iii37

Influence of treatment on morphological features of mucosal inflammation

K Geboes, I Dalle
PMCID: PMC1867680  PMID: 11953331

Full Text

The Full Text of this article is available as a PDF (123.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andre C., Descos L., Landais P., Fermanian J. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut. 1981 Jul;22(7):571–574. doi: 10.1136/gut.22.7.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baert F. J., D'Haens G. R., Peeters M., Hiele M. I., Schaible T. F., Shealy D., Geboes K., Rutgeerts P. J. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology. 1999 Jan;116(1):22–28. doi: 10.1016/s0016-5085(99)70224-6. [DOI] [PubMed] [Google Scholar]
  3. Beattie R. M., Schiffrin E. J., Donnet-Hughes A., Huggett A. C., Domizio P., MacDonald T. T., Walker-Smith J. A. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther. 1994 Dec;8(6):609–615. doi: 10.1111/j.1365-2036.1994.tb00338.x. [DOI] [PubMed] [Google Scholar]
  4. Bernstein C. N., Shanahan F., Anton P. A., Weinstein W. M. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc. 1995 Sep;42(3):232–237. doi: 10.1016/s0016-5107(95)70097-8. [DOI] [PubMed] [Google Scholar]
  5. Best W. R., Becktel J. M., Singleton J. W., Kern F., Jr Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439–444. [PubMed] [Google Scholar]
  6. Bitton A., Peppercorn M. A., Antonioli D. A., Niles J. L., Shah S., Bousvaros A., Ransil B., Wild G., Cohen A., Edwardes M. D. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001 Jan;120(1):13–20. doi: 10.1053/gast.2001.20912. [DOI] [PubMed] [Google Scholar]
  7. Breese E. J., Michie C. A., Nicholls S. W., Williams C. B., Domizio P., Walker-Smith J. A., MacDonald T. T. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther. 1995 Oct;9(5):547–552. doi: 10.1111/j.1365-2036.1995.tb00419.x. [DOI] [PubMed] [Google Scholar]
  8. Campieri M., Lanfranchi G. A., Bazzocchi G., Brignola C., Sarti F., Franzin G., Battocchia A., Labo G., Dal Monte P. R. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet. 1981 Aug 8;2(8241):270–271. doi: 10.1016/s0140-6736(81)90523-7. [DOI] [PubMed] [Google Scholar]
  9. Cook M. G., Dixon M. F. An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut. 1973 Apr;14(4):255–262. doi: 10.1136/gut.14.4.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cross S. S. Grading and scoring in histopathology. Histopathology. 1998 Aug;33(2):99–106. doi: 10.1046/j.1365-2559.1998.00495.x. [DOI] [PubMed] [Google Scholar]
  11. D'Haens G. R., Geboes K., Peeters M., Baert F., Penninckx F., Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998 Feb;114(2):262–267. doi: 10.1016/s0016-5085(98)70476-7. [DOI] [PubMed] [Google Scholar]
  12. D'Haens G., Geboes K., Ponette E., Penninckx F., Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology. 1997 May;112(5):1475–1481. doi: 10.1016/s0016-5085(97)70027-1. [DOI] [PubMed] [Google Scholar]
  13. D'haens G., Van Deventer S., Van Hogezand R., Chalmers D., Kothe C., Baert F., Braakman T., Schaible T., Geboes K., Rutgeerts P. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology. 1999 May;116(5):1029–1034. doi: 10.1016/s0016-5085(99)70005-3. [DOI] [PubMed] [Google Scholar]
  14. Danielsson A., Hellers G., Lyrenäs E., Löfberg R., Nilsson A., Olsson O., Olsson S. A., Persson T., Salde L., Naesdal J. A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand J Gastroenterol. 1987 Oct;22(8):987–992. doi: 10.3109/00365528708991947. [DOI] [PubMed] [Google Scholar]
  15. Danielsson A., Löfberg R., Persson T., Salde L., Schiöler R., Suhr O., Willén R. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand J Gastroenterol. 1992;27(1):9–12. doi: 10.3109/00365529209011158. [DOI] [PubMed] [Google Scholar]
  16. Florén C. H., Benoni C., Willén R. Histologic and colonoscopic assessment of disease extension in ulcerative colitis. Scand J Gastroenterol. 1987 May;22(4):459–462. doi: 10.3109/00365528708991491. [DOI] [PubMed] [Google Scholar]
  17. Geboes K., Desreumaux P., Jouret A., Ectors N., Rutgeerts P., Colombel J. F. Diagnostic histopathologique de l'activité des maladies inflammatoires chroniques de l'intestin. Evaluation de l'effet des traitements médicamenteux. Application des scores histologiques. Gastroenterol Clin Biol. 1999 Oct;23(10):1062–1073. [PubMed] [Google Scholar]
  18. Geboes K., Ectors N., D'Haens G., Rutgeerts P. Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease? Am J Gastroenterol. 1998 Feb;93(2):201–206. doi: 10.1111/j.1572-0241.1998.00201.x. [DOI] [PubMed] [Google Scholar]
  19. Geboes K. From inflammation to lesion. Acta Gastroenterol Belg. 1994 Sep-Dec;57(5-6):273–284. [PubMed] [Google Scholar]
  20. Geboes K., Riddell R., Ost A., Jensfelt B., Persson T., Löfberg R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000 Sep;47(3):404–409. doi: 10.1136/gut.47.3.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Goldman H. Interpretation of large intestinal mucosal biopsy specimens. Hum Pathol. 1994 Nov;25(11):1150–1159. doi: 10.1016/0046-8177(94)90031-0. [DOI] [PubMed] [Google Scholar]
  22. Gomes P., du Boulay C., Smith C. L., Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986 Jan;27(1):92–95. doi: 10.1136/gut.27.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Harvey R. F., Bradshaw J. M. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514–514. doi: 10.1016/s0140-6736(80)92767-1. [DOI] [PubMed] [Google Scholar]
  24. Hawkey C. J., Dube L. M., Rountree L. V., Linnen P. J., Lancaster J. F. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis. Gastroenterology. 1997 Mar;112(3):718–724. doi: 10.1053/gast.1997.v112.pm9041232. [DOI] [PubMed] [Google Scholar]
  25. Henrikson C. K., Argenzio R. A., Liacos J. A., Khosla J. Morphologic and functional effects of bile salt on the porcine colon during injury and repair. Lab Invest. 1989 Jan;60(1):72–87. [PubMed] [Google Scholar]
  26. Holdstock G., DuBoulay C. E., Smith C. L. Survey of the use of colonoscopy in inflammatory bowel disease. Dig Dis Sci. 1984 Aug;29(8):731–734. doi: 10.1007/BF01312946. [DOI] [PubMed] [Google Scholar]
  27. Jenkins D., Balsitis M., Gallivan S., Dixon M. F., Gilmour H. M., Shepherd N. A., Theodossi A., Williams G. T. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol. 1997 Feb;50(2):93–105. doi: 10.1136/jcp.50.2.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jenkins D., Goodall A., Drew K., Scott B. B. What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol. 1988 Jan;41(1):72–79. doi: 10.1136/jcp.41.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Keren D. F., Appelman H. D., Dobbins W. O., 3rd, Wells J. J., Whisenant B., Foley J., Dieterle R., Geisinger K. Correlation of histopathologic evidence of disease activity with the presence of immunoglobulin-containing cells in the colons of patients with inflammatory bowel disease. Hum Pathol. 1984 Aug;15(8):757–763. doi: 10.1016/s0046-8177(84)80167-7. [DOI] [PubMed] [Google Scholar]
  30. Kleer C. G., Appelman H. D. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol. 1998 Aug;22(8):983–989. doi: 10.1097/00000478-199808000-00008. [DOI] [PubMed] [Google Scholar]
  31. Korelitz B. I., Sommers S. C. Response to drug therapy in Crohn's disease: evaluation by rectal biopsy and mucosal cell counts. J Clin Gastroenterol. 1984 Apr;6(2):123–127. doi: 10.1097/00004836-198404000-00005. [DOI] [PubMed] [Google Scholar]
  32. Landi B., Anh T. N., Cortot A., Soule J. C., Rene E., Gendre J. P., Bories P., See A., Metman E. H., Florent C. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology. 1992 May;102(5):1647–1653. doi: 10.1016/0016-5085(92)91725-j. [DOI] [PubMed] [Google Scholar]
  33. MacDonald T. T. The role of activated T lymphocytes in gastrointestinal disease. Clin Exp Allergy. 1990 May;20(3):247–252. doi: 10.1111/j.1365-2222.1990.tb02679.x. [DOI] [PubMed] [Google Scholar]
  34. MacIntosh D. G., Thompson W. G., Patel D. G., Barr R., Guindi M. Is rectal biopsy necessary in irritable bowel syndrome? Am J Gastroenterol. 1992 Oct;87(10):1407–1409. [PubMed] [Google Scholar]
  35. Mary J. Y., Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut. 1989 Jul;30(7):983–989. doi: 10.1136/gut.30.7.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mulder C. J., Fockens P., Meijer J. W., van der Heide H., Wiltink E. H., Tytgat G. N. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis. Eur J Gastroenterol Hepatol. 1996 Jun;8(6):549–553. doi: 10.1097/00042737-199606000-00010. [DOI] [PubMed] [Google Scholar]
  37. Nicholls S., Domizio P., Williams C. B., Dawnay A., Braegger C. P., MacDonald T. T., Walker-Smith J. A. Cyclosporin as initial treatment for Crohn's disease. Arch Dis Child. 1994 Sep;71(3):243–247. doi: 10.1136/adc.71.3.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Nostrant T. T., Kumar N. B., Appelman H. D. Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology. 1987 Feb;92(2):318–328. doi: 10.1016/0016-5085(87)90124-7. [DOI] [PubMed] [Google Scholar]
  39. Odze R., Antonioli D., Peppercorn M., Goldman H. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol. 1993 Sep;17(9):869–875. doi: 10.1097/00000478-199309000-00002. [DOI] [PubMed] [Google Scholar]
  40. Olaison G., Sjödahl R., Tagesson C. Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation. Gut. 1990 Mar;31(3):325–328. doi: 10.1136/gut.31.3.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Oshitani N., Campbell A., Kitano A., Kobayashi K., Jewell D. P. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa. J Pathol. 1996 Jan;178(1):95–99. doi: 10.1002/(SICI)1096-9896(199601)178:1<95::AID-PATH402>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  42. Powell-Tuck J., Day D. W., Buckell N. A., Wadsworth J., Lennard-Jones J. E. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci. 1982 Jun;27(6):533–537. doi: 10.1007/BF01296733. [DOI] [PubMed] [Google Scholar]
  43. Quinn P. G., Binion D. G., Connors P. J. The role of endoscopy in inflammatory bowel disease. Med Clin North Am. 1994 Nov;78(6):1331–1352. doi: 10.1016/s0025-7125(16)30104-3. [DOI] [PubMed] [Google Scholar]
  44. Riley S. A., Mani V., Goodman M. J., Dutt S., Herd M. E. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991 Feb;32(2):174–178. doi: 10.1136/gut.32.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Riley S. A., Mani V., Goodman M. J., Herd M. E., Dutt S., Turnberg L. A. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. Gut. 1988 May;29(5):669–674. doi: 10.1136/gut.29.5.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Roberts W. G., Simon T. J., Berlin R. G., Haggitt R. C., Snyder E. S., Stenson W. F., Hanauer S. B., Reagan J. E., Cagliola A., Tanaka W. K. Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. Gastroenterology. 1997 Mar;112(3):725–732. doi: 10.1053/gast.1997.v112.pm9041233. [DOI] [PubMed] [Google Scholar]
  47. Rubio C. A., Johansson C., Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. II. Normal limits in symptomatic patients. Scand J Gastroenterol. 1982 Nov;17(8):1077–1081. [PubMed] [Google Scholar]
  48. Rubio C. A., Johansson C., Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. III. Chronic ulcerative colitis. Scand J Gastroenterol. 1982 Nov;17(8):1083–1087. [PubMed] [Google Scholar]
  49. Rubio C. A., Johansson C., Uribe A., Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. IV. Ulcerative colitis in remission. Scand J Gastroenterol. 1984 Jun;19(4):525–530. [PubMed] [Google Scholar]
  50. Sandborn W. J., Van O E. C., Zins B. J., Tremaine W. J., Mays D. C., Lipsky J. J. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease. Gastroenterology. 1995 Dec;109(6):1808–1817. doi: 10.1016/0016-5085(95)90747-5. [DOI] [PubMed] [Google Scholar]
  51. Schmitz-Moormann P., Brandes J. W., Jesdinsky H., Knapp M. Relationships between drug regime and histology of rectal mucosa in Crohn's disease. Pathol Res Pract. 1988 Feb;183(1):30–34. doi: 10.1016/S0344-0338(88)80155-9. [DOI] [PubMed] [Google Scholar]
  52. Schmitz-Moormann P., Himmelmann G. W. Does quantitative histology of rectal biopsy improve the differential diagnosis of Crohn's disease and ulcerative colitis in adults? Pathol Res Pract. 1988 Aug;183(4):481–488. doi: 10.1016/S0344-0338(88)80097-9. [DOI] [PubMed] [Google Scholar]
  53. Schumacher G., Kollberg B., Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. Scand J Gastroenterol. 1994 Apr;29(4):318–332. doi: 10.3109/00365529409094843. [DOI] [PubMed] [Google Scholar]
  54. Scott B. B., Goodall A., Stephenson P., Jenkins D. Rectal mucosal plasma cells in inflammatory bowel disease. Gut. 1983 Jun;24(6):519–524. doi: 10.1136/gut.24.6.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Seldenrijk C. A., Morson B. C., Meuwissen S. G., Schipper N. W., Lindeman J., Meijer C. J. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut. 1991 Dec;32(12):1514–1520. doi: 10.1136/gut.32.12.1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Smedh K., Olaison G., Franzén L., Sjödahl R. The endoscopic picture reflects transmural inflammation better than endoscopic biopsy in Crohn's disease. Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1189–1193. doi: 10.1097/00042737-199612000-00011. [DOI] [PubMed] [Google Scholar]
  57. Ståhlberg D., Veress B., Måre K., Granqvist S., Agren B., Richter S., Löfberg R. Leukocyte migration in acute colonic inflammatory bowel disease: comparison of histological assessment and Tc-99m-HMPAO labeled leukocyte scan. Am J Gastroenterol. 1997 Feb;92(2):283–288. [PubMed] [Google Scholar]
  58. Surawicz C. M., Belic L. Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology. 1984 Jan;86(1):104–113. [PubMed] [Google Scholar]
  59. TRUELOVE S. C., HORLER A. R., RICHARDS W. C. Serial biopsy in ulcerative colitis. Br Med J. 1955 Dec 31;2(4956):1590–1593. doi: 10.1136/bmj.2.4956.1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. TRUELOVE S. C., RICHARDS W. C. Biopsy studies in ulcerative colitis. Br Med J. 1956 Jun 9;1(4979):1315–1318. doi: 10.1136/bmj.1.4979.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Theodossi A., Spiegelhalter D. J., Jass J., Firth J., Dixon M., Leader M., Levison D. A., Lindley R., Filipe I., Price A. Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut. 1994 Jul;35(7):961–968. doi: 10.1136/gut.35.7.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Tsang P., Rotterdam H. Biopsy diagnosis of colitis: possibilities and pitfalls. Am J Surg Pathol. 1999 Apr;23(4):423–430. doi: 10.1097/00000478-199904000-00006. [DOI] [PubMed] [Google Scholar]
  64. Waye J. D. Endoscopy in inflammatory bowel disease: indications and differential diagnosis. Med Clin North Am. 1990 Jan;74(1):51–65. doi: 10.1016/s0025-7125(16)30586-7. [DOI] [PubMed] [Google Scholar]
  65. Weldon M. J., Masoomi A. M., Britten A. J., Gane J., Finlayson C. J., Joseph A. E., Maxwell J. D. Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT). Gut. 1995 Feb;36(2):243–250. doi: 10.1136/gut.36.2.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Whitehead R. Colitis: problems in definition and diagnosis. Virchows Arch A Pathol Anat Histopathol. 1990;417(3):187–190. doi: 10.1007/BF01600132. [DOI] [PubMed] [Google Scholar]
  67. Wright R., Truelove S. C. Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis. 1966 Nov;11(11):831–846. doi: 10.1007/BF02233940. [DOI] [PubMed] [Google Scholar]
  68. Wright R., Truelove S. R. Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets. Am J Dig Dis. 1966 Nov;11(11):847–857. doi: 10.1007/BF02233941. [DOI] [PubMed] [Google Scholar]
  69. Yardley J. H., Donowitz M. Colo-rectal biopsy in inflammatory bowel disease. Monogr Pathol. 1977;(18):50–94. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES